Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer

Savio Barreto, Shailesh V Shrikhande, Bhawna Sirohi

Research output: Contribution to journalEditorial


In this perspective, we present our assessment of all of the known accumulated evidence on the role of neoadjuvant therapy in the management of borderline resectable pancreatic cancer highlighting the gaps in the data, the current regimens used and providing a brief insight into the way forward.
Original languageEnglish
Number of pages6
JournalIndian Journal of Surgical Oncology
Publication statusE-pub ahead of print - 1 Jul 2021


  • Neodajuvant Therapy
  • Pancreatic Cancer


Dive into the research topics of 'Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer'. Together they form a unique fingerprint.

Cite this